Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 29, 1999

View Archived Issues

Published Data Show Infliximab Also Helps Stop Joint Damage

CAT Partners With Searle In Deal Worth Up To US$150M

MorphoSys, Bayer Form Broad Collaboration Around Antibodies

UK Genomics Initiative Involves Collection Of DNA For Database

Paladin Acquires Neurocrine Program To Broaden Pipeline

Juvantia Pharma Enters Clinic With Anti-Parkinson's Candidate

Australian Researchers Discover Genes Linked To Obesity, Testes

Matrix Moves Right Into Clinic Following Recent Formation

Evotec Enters Agreement To Screen 10 Targets For Knoll

European Patent Board Affirms Patentability Of Plants, Animals

NicOx Begins Phase II Study Of Paget's Disease Candidate

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.